Observational studyEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Impact of subthalamic nucleus deep brain stimulation on voice and speech in Parkinson's disease.
Observational study in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeSubthalamic nucleus deep brain stimulation (STN-DBS) effectively alleviates motor symptoms in Parkinson’s disease (PD), yet its impact on speech and voice remains inconsistent. This study examined acoustic parameters, perceptual features, and speech intelligibility using a large, methodologically standardized cohort.
methodsA total of 105 PD patients (55 females, 50 males; mean age ≈ 57 years) undergoing STN-DBS were evaluated. All received posterolateral electrode placement, bilateral stimulation, and a postoperative 30–35% reduction in levodopa. Acoustic measures fundamental frequency (F0), jitter, shimmer, harmonic-to-noise ratio (HNR), and maximum phonation time (MPT) were obtained one day preoperatively and at three months postoperatively. Perceptual ratings (GRBAS), Voice Handicap Index-10 (VHI-10), and speech intelligibility (percentage of correctly produced words) were assessed concurrently.
resultsMotor symptoms improved in the medication-on state (19.4 → 13.6). Acoustic analysis showed no significant postoperative change in F0, shimmer, HNR, or MPT; however, jitter improved significantly in both sexes. On the GRBAS scale, all parameters improved in females, whereas grade, roughness, and asthenia improved in males. VHI-10 scores improved overall (22.7 → 21.8; p = 0.031), driven primarily by females (27.5 → 25.9; p = 0.004). Speech intelligibility increased in the full cohort (70.1% → 71.7%; p = 0.01) and reached significance in females but not males. Higher age and greater motor severity correlated with reduced intelligibility, while sex, PD subtype, and stimulation parameters showed no associations.
conclusionSTN-DBS yields short-term motor improvement and produces parameter-specific speech effects. Utilizing a highly standardized “pure” cohort enhances interpretability and suggests that, under controlled conditions, STN-DBS can exert a beneficial influence on speech performance despite its multifactorial impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.